This conference is financed through INFRAPLUS project‘s funding received from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101131669.
Conference Programme
INFRAFRONTIER Conference 2026
Explore the programme and get ready for an inspiring event filled with top speakers and engaging sessions!

INFRAFRONTIER CONFERENCE 2026
Over two days, the conference will follow a clear scientific progression, from computational foundations to translational implementation, structured into five thematic sessions:

With these sessions, we will examine the future role of computational disease models as complements to in vivo and in vitro systems: under what conditions can they enhance predictive power, improve translational relevance, and guide experimental design more efficiently? Where are the current limits (conceptual, technical, and biological) and which bottlenecks (data quality, interoperability, mechanistic interpretability, benchmarking, governance) must be overcome to move from promising prototypes to robust, actionable models?
Each session will feature *internationally recognised invited speakers+ as well as selected contributions from submitted abstracts. Several sessions will include interactive workshop elements and structured on-stage discussions, designed to surface critical disagreements, define shared benchmarks, and clarify what “success” should look like for in silico disease modeling. Both conference days will conclude with panel discussions focused on the most pressing bottlenecks and the most promising routes forward.
Fulll programme coming soon!
Scientific Programme Committee
Dr Ana Zarubica
Dr Anna Moles
Dr Lluis Montoliu
Dr Radislav Sedláček
Dr Yann Herault
Director of the Mouse Clinical Institute, (“Institute Clinique de la Souris”, MCI/ICS), Strasbourg (France).
Research Team Leader at the IGBMC, Strasbourg (France).
Prof Dr Johannes Beckers
Dr Michael Raess
Dr Asrar Ali Khan
Dalia Puig
Do you have questions?
We’re here to help! Reach out to us at
